Use of inj. Botox to the Abdominal Wall in Large Incisional Hernia Repair : A Local Experience in a Tertiary Hospital in Singapore
Published: 2024-04-12
Page: 198-206
Issue: 2024 - Volume 7 [Issue 1]
Irene Wen-Hui Tu
Singapore Health Group (Sing Health), Singapore.
Tirukonda Prasanna Sivanath
Singapore Health Group (Sing Health), Singapore and Changi General Hospital, Singapore.
Sulaiman Bin Yusof
Singapore Health Group (Sing Health), Singapore and Changi General Hospital, Singapore.
Ong Jianming Calvin *
Singapore Health Group (Sing Health), Singapore and Changi General Hospital, Singapore.
*Author to whom correspondence should be addressed.
Abstract
Large incisional hernias are challenging to manage even with techniques like Component Separation (CS). Although chemical component separation with botulinum toxin A (BTA) prior to surgical repair has gained popularity over the years, it still remains poorly described in Southeast Asian literature. We share our local experience using BTA as an adjunct prior to CS in the repair of a large 8 x 15 cm incisional hernia. 3 weeks before surgical repair of his hernia, 300 IU of BTA was injected over 3 sites of the lateral abdominal wall (LAW) muscles bilaterally. The patient subsequently underwent elective surgery and was discharged well on post operative day 5. A CT scan was done at 3 month showing no recurrence and sustained lengthening of his LAW muscles. In conclusion, low dose BTA increases LAW muscle length, facilitates fascial closure without tension as well as increasing abdominal cavity volume hence promoting better physiological postoperative adaptation. Despite being a useful adjunct in the management of large incisional hernias, there is significant variation in the dosage, concentration and techniques in which BTA is administered, as well as the optimal duration for administration prior to surgery. Further studies would have to be performed to obtain a consensus as to the best practice for the use of BTA.
Keywords: Botulinum toxin A, chemical component separation, Large Incisional hernia, lateral abdominal wall
How to Cite
Downloads
References
Ramirez OM, Ruas E, Dellon AL. Components separation method for closure of abdominal-wall defects: an anatomic and clinical study. Plast Reconstr Surg. 1990;86:519–26. DOI: 10.1097/00006534-199009000-00023
Moreno IG. Chronic eventrations and large hernias; Preoperative treatment by progressive pneumoperitomeum; Original procedure. Surgery. 1947;22:945–53.
Gillion JF, Sanders D, Miserez M, et al. The economic burden of incisional venetral hernia repair: a multicentric cost analysis. Hernia 2016;20:819-830.
Sanders DL, Pawlak MM, de Beaux AC. European Hernia Society incisional hernia guidelines. British Journal of Surgery. 2023; 110(3):343-.
Reshma Brahmbhatt, Stacey A. Carter, Stephanie C. Hicks, David H. Berger, and Mike K. Liang. Identifying risk factors for surgical site complications after laparoscopic ventral hernia repair: Evaluation of the ventral hernia working group grading system. Surgical Infections. 2014;15:3: 187-193
Ibarra-Hurtado TR, Nuño-Guzmán CM, Echeagaray-Herrera JE, Robles- Vélez E, de Jesús González-Jaime J. Use of botulinum toxin type a before abdominal wall hernia reconstruction. World J Surg. 2009;33:2553–6. DOI: 10.1007/s00268-009-0203-3
Zielinski MD, Goussous N, Schiller HJ, Jenkins D. Chemical components separation with botulinum toxin A: A novel technique to improve primary fascial closure rates of the open abdomen. Hernia. 2013;17:101–7. DOI: 10.1007/s10029-012-0995-1
Whitehead-Clarke Thomas, Windsor Alastair. The Use of Botulinum Toxin in Complex Hernia Surgery: Achieving a Sense of Closure. Frontiers in Surgery; 2021. DOI:10.3389/fsurg.2021.753889
Rodriguez-Acevedo O, Elstner KE, Jacombs ASW, Read JW, Martins RT, Arduini F, et al. Preoperative Botulinum toxin A enabling defect closure and laparoscopic repair of complex ventral hernia. Surg Endosc. 2018;32:831–9. DOI: 10.1007/s00464-017-5750-3
Jacombs A, Elstner K, Rodriguez-Acevedo O, Read JW, Ho-Shon K, Wehrhahn M, et al. Seven years of preoperative BTA abdominal wall preparation and the Macquarie system for surgical management of complex ventral hernia. Hernia; 2021. DOI: 10.1007/s10029-021-02428-2
Yurtkap Y, van Rooijen MMJ, Roels S, Bosmans JML, Uyttebroek O, Lange JF, et al. Implementing preoperative Botulinum toxin A and progressive pneumoperitoneum through the use of an algorithm in giant ventral hernia repair. Hernia. 2021;25:389–98. DOI: 10.1007/s10029-020-02226-2
Bueno-Lledó J, Carreño-Saenz O, Torregrosa-Gallud A, Pous-Serrano S. Preoperative botulinum toxin and progressive pneumoperitoneum in loss of domain hernias-our first 100 cases. Front Surg. 2020;7:3. DOI: 10.3389/fsurg.2020.00003
Zendejas B, Khasawneh MA, Srvantstyan B, Jenkins DH, Schiller HJ, Zielinski MD. Outcomes of chemical component paralysis using botulinum toxin for incisional hernia repairs. World J Surg. 2013;37:2830–7. DOI: 10.1007/s00268-013-2211-6
Soltanizadeh S, Helgstrand F, Jorgensen LN. Botulinum toxin a as an adjunct to abdominal wall reconstruction for incisional hernia. Plast Reconstr Surg Glob Open. 2017;5(6):e1358. DOI 10.1097/GOX.0000000000001358.
Lien SC, Hu Y, Wollstein A, Franz MG, Patel SP, Kuzon WM, Urbanchek MG. Contraction of abdominal wall muscles influences size and occurrence of incisional hernia. Surgery. 2015;158:278–88. Available:https://doi.org/10.1016/j.surg.2015.01.023.
Dressler D. Clinical applications of botulinum toxin. Curr. Opin. Microbiol. 2012;15:325–336. DOI: 10.1016/j.mib.2012.05.012
Elstner KE, Read JW, Rodriguez -Acevedo O, Ho-Shon K, Magnussen J, Ibrahim N. Preoperative progressive pneumoperitoneum complementing chemical component relaxation in complex ventral hernia repair. Surg Endosc. 2017; 31:1914–22. Available:https://doi.org/10.1007/s00464-016-5194-1
A.S Timmer, J.J.M Claessen, J.J. Atema, MVH Rutten, R Hompes, MA Boermeester. A systematic review and meta-analysis of technical aspects and clinical outcomes of botulinum toxin prior to abdominal wall reconstruction. Hernia. 2021;25(6):1413–1425. 2021 DOI: 10.1007/s10029-021-02499-1
Farooque F, Jacombs AS, Roussos E, Read JW, Dardano AN, et al. Preoperative abdominal muscle elongation with botulinum toxin A for complex incisional ventral hernia repair. ANZ J Surg. 2016;86: 79–83.
Rodriguez-Acevedo O, Elstner KE, Jacombs ASW, Read JW, Martins RT, et al. Preoperative botulinum toxin A enabling defect closure and laparoscopic repair of complex ventral hernia. Surg Endosc. 2018;32:831–9.
D Moszkowicz, Y Renard, B Romain, J F Gillion, P Ortega-Deballon, G Passot British Journal of Surgery. 2022;109: Supplement_7:znac308.17. Available:https://doi.org/10.1093/bjs/znac308.175 P-077 Surgical treatment of large incisional hernia with Botulinum Toxin A injection: study protocol for a double blind randomized controlled trial.
Hoffman, Henry, Nowakowski, Deborah, Kirchhoff, Phillip. Chemical abdominal wall release using botulinum toxin A. A personal view. International Journal of Abdominal Wall and Hernia Surgery. 2022;5(1)30-35, DOI: 10.4103/ijawhs.ijawhs_46_21